{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:51:58Z","timestamp":1778698318820,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11255-017-1692-x","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T11:21:17Z","timestamp":1506079277000},"page":"1999-2003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Kidney involvement in psoriasis: a case\u2013control study from China"],"prefix":"10.1007","volume":"49","author":[{"given":"Fang","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9238-4181","authenticated-orcid":false,"given":"Hong","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"issue":"3","key":"1692_CR1","first-page":"173","volume":"95","author":"E Edson-Heredia","year":"2015","unstructured":"Edson-Heredia E et al (2015) Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys. Cutis 95(3):173\u2013178","journal-title":"Cutis"},{"issue":"2","key":"1692_CR2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10067-015-3126-4","volume":"35","author":"L Visconti","year":"2016","unstructured":"Visconti L et al (2016) Kidney disease and psoriasis: novel evidences beyond old concepts. Clin Rheumatol 35(2):297\u2013302","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1692_CR3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361(5):496\u2013509","journal-title":"N Engl J Med"},{"issue":"9583","key":"1692_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370(9583):263\u2013271","journal-title":"Lancet"},{"key":"1692_CR5","doi-asserted-by":"crossref","unstructured":"Paneni F et al (2013) Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction. Circulation 127(11):1229\u20131240, e1\u201321","DOI":"10.1161\/CIRCULATIONAHA.112.000826"},{"issue":"Suppl 7","key":"1692_CR6","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.4103\/0378-6323.115506","volume":"79","author":"SJ Aurangabadkar","year":"2013","unstructured":"Aurangabadkar SJ (2013) Comorbidities in psoriasis. Indian J Dermatol Venereol Leprol 79(Suppl 7):S10\u2013S17","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"1692_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000045359","volume":"82","author":"J Heuvels","year":"1999","unstructured":"Heuvels J et al (1999) Renal abnormalities in psoriatic patients: a review. Nephron 82(1):1\u20136","journal-title":"Nephron"},{"issue":"9","key":"1692_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1346-8138.2000.tb02230.x","volume":"27","author":"JC Szepietowski","year":"2000","unstructured":"Szepietowski JC, Szepietowski T (2000) Is renal function altered in patients with psoriasis vulgaris? A short review. J Dermatol 27(9):569\u2013572","journal-title":"J Dermatol"},{"issue":"9","key":"1692_CR9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3109\/08860220903180582","volume":"31","author":"H Akoglu","year":"2009","unstructured":"Akoglu H et al (2009) Membranoproliferative glomerulonephritis associated with psoriasis vulgaris. Ren Fail 31(9):858\u2013861","journal-title":"Ren Fail"},{"issue":"4","key":"1692_CR10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","volume":"11","author":"JR Chapman","year":"2011","unstructured":"Chapman JR (2011) Chronic calcineurin inhibitor nephrotoxicity-lest we forget. Am J Transplant 11(4):693\u2013697","journal-title":"Am J Transplant"},{"issue":"6","key":"1692_CR11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","volume":"11","author":"BC Widemann","year":"2006","unstructured":"Widemann BC, Adamson PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11(6):694\u2013703","journal-title":"Oncologist"},{"issue":"6","key":"1692_CR12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1468-3083.2000.00119.x","volume":"14","author":"JC Szepietowski","year":"2000","unstructured":"Szepietowski JC et al (2000) Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol 14(6):513\u2013514","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1692_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/09546634.2013.879094","volume":"26","author":"MG Debbaneh","year":"2015","unstructured":"Debbaneh MG et al (2015) Plaque-based sub-blistering dosimetry: reaching PASI-75 after two treatments with 308-nm excimer laser in a generalized psoriasis patient. J Dermatolog Treat 26(1):45\u201348","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"1692_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1590\/abd1806-4841.20164169","volume":"91","author":"J Machado-Pinto","year":"2016","unstructured":"Machado-Pinto J, Diniz MS, Bavoso NC (2016) Psoriasis: new comorbidities. An Bras Dermatol 91(1):8\u201314","journal-title":"An Bras Dermatol"},{"key":"1692_CR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000246358","volume":"192","author":"O Kaftan","year":"1996","unstructured":"Kaftan O et al (1996) Renal involvement in psoriasis. Dermatology 192:189\u2013190","journal-title":"Dermatology"},{"issue":"3","key":"1692_CR16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","volume":"78","author":"CC Chi","year":"2015","unstructured":"Chi CC et al (2015) Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci 78(3):232\u2013238","journal-title":"J Dermatol Sci"},{"issue":"8287","key":"1692_CR17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","volume":"1","author":"GC Viberti","year":"1982","unstructured":"Viberti GC et al (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1(8287):1430\u20131432","journal-title":"Lancet"},{"issue":"12","key":"1692_CR18","first-page":"1713","volume":"9","author":"CM Erley","year":"1994","unstructured":"Erley CM, Risler T (1994) Microalbuminuria in primary hypertension: is it a marker of glomerular damage? Nephrol Dial Transplant 9(12):1713\u20131715","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1692_CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ndt\/12.3.379","volume":"12","author":"R Pedrinelli","year":"1997","unstructured":"Pedrinelli R (1997) Microalbuminuria in essential hypertension. A marker of systemic vascular damage? Nephrol Dial Transplant 12(3):379\u2013381","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"1692_CR20","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/oxfordjournals.ndt.a027119","volume":"11","author":"R Pontremoli","year":"1996","unstructured":"Pontremoli R (1996) Microalbuminuria in essential hypertension\u2014its relation to cardiovascular risk factors. Nephrol Dial Transplant 11(11):2113\u20132115","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1692_CR21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11255-011-9966-1","volume":"44","author":"E Dervisoglu","year":"2012","unstructured":"Dervisoglu E et al (2012) The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol 44(2):509\u2013514","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1692_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/1523-1747.ep12625852","volume":"59","author":"IM Braverman","year":"1972","unstructured":"Braverman IM (1972) Electron microscopic studies of the microcirculation in psoriasis. J Invest Dermatol 59(1):91\u201398","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1692_CR23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lsm.20977","volume":"43","author":"J Qin","year":"2011","unstructured":"Qin J et al (2011) In vivo volumetric imaging of microcirculation within human skin under psoriatic conditions using optical microangiography. Lasers Surg Med 43(2):122\u2013129","journal-title":"Lasers Surg Med"},{"issue":"1","key":"1692_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1056-8727(97)00045-7","volume":"12","author":"CY Hong","year":"1998","unstructured":"Hong CY, Chia KS (1998) Markers of diabetic nephropathy. J Diabetes Complications 12(1):43\u201360","journal-title":"J Diabetes Complications"},{"issue":"5","key":"1692_CR25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1056-8727(00)00119-7","volume":"14","author":"CY Hong","year":"2000","unstructured":"Hong CY, Chia KS, Ling SL (2000) Urinary protein excretion in type 2 diabetes with complications. J Diabetes Complications 14(5):259\u2013265","journal-title":"J Diabetes Complications"},{"issue":"12","key":"1692_CR26","first-page":"569","volume":"13","author":"TL Revert","year":"1996","unstructured":"Revert TL (1996) Diabetic nephropathy. An Med Interna 13(12):569\u2013571","journal-title":"An Med Interna"},{"issue":"6","key":"1692_CR27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jcla.20212","volume":"21","author":"A Mohammadi-Karakani","year":"2007","unstructured":"Mohammadi-Karakani A et al (2007) Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal 21(6):413\u2013417","journal-title":"J Clin Lab Anal"},{"issue":"7049","key":"1692_CR28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","volume":"436","author":"Q Yang","year":"2005","unstructured":"Yang Q et al (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436(7049):356\u2013362","journal-title":"Nature"},{"key":"1692_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/BMI.S33191","volume":"11","author":"MH Mahfouz","year":"2016","unstructured":"Mahfouz MH et al (2016) Assessment of neutrophil gelatinase-associated lipocalin (NGAL) and retinol-binding protein 4 (RBP4) in type 2 diabetic patients with nephropathy. Biomark Insights 11:31\u201340","journal-title":"Biomark Insights"},{"key":"1692_CR30","doi-asserted-by":"crossref","first-page":"f5961","DOI":"10.1136\/bmj.f5961","volume":"347","author":"J Wan","year":"2013","unstructured":"Wan J et al (2013) Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ 347:f5961","journal-title":"BMJ"},{"issue":"4","key":"1692_CR31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1590\/abd1806-4841.20132035","volume":"88","author":"SS Melga\u00e7o","year":"2013","unstructured":"Melga\u00e7o SS et al (2013) Evaluation of renal function in patients with psoriasis using immunobiologicals. An Bras Dermatol 88(4):667\u2013669","journal-title":"An Bras Dermatol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1692-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1692-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1692-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T06:37:03Z","timestamp":1508135823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1692-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1692-x","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,22]]}}}